These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22904132)

  • 1. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2.
    Panarelli NC; Yantiss RK; Yeh MM; Liu Y; Chen YT
    Am J Clin Pathol; 2012 Aug; 138(2):211-22. PubMed ID: 22904132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2.
    Altree-Tacha D; Tyrrell J; Haas T
    Arch Pathol Lab Med; 2017 Jan; 141(1):144-150. PubMed ID: 28029907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDH17+/CDX2+ Can be Helpful in Providing Support for Small Intestinal Origin Versus Pancreatic or Biliary Origin.
    Ma H; Xiao W; Wang M; Shi X
    Appl Immunohistochem Mol Morphol; 2021 Aug; 29(7):541-545. PubMed ID: 33958523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer.
    Ito R; Oue N; Yoshida K; Kunimitsu K; Nakayama H; Nakachi K; Yasui W
    Virchows Arch; 2005 Oct; 447(4):717-22. PubMed ID: 16044349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases.
    Schmitt AM; Riniker F; Anlauf M; Schmid S; Soltermann A; Moch H; Heitz PU; Klöppel G; Komminoth P; Perren A
    Am J Surg Pathol; 2008 Mar; 32(3):420-5. PubMed ID: 18300808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall.
    Mazziotta RM; Borczuk AC; Powell CA; Mansukhani M
    Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):55-60. PubMed ID: 15722794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas.
    Werling RW; Yaziji H; Bacchi CE; Gown AM
    Am J Surg Pathol; 2003 Mar; 27(3):303-10. PubMed ID: 12604886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma.
    Ge J; Chen Z; Wu S; Yuan W; Hu B; Chen Z
    Clin Oncol (R Coll Radiol); 2008 May; 20(4):275-83. PubMed ID: 18353622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases.
    Malmros K; Lindholm A; Vidarsdottir H; Jirström K; Nodin B; Botling J; Mattsson JSM; Micke P; Planck M; Jönsson M; Staaf J; Brunnström H
    Virchows Arch; 2024 Aug; 485(2):347-357. PubMed ID: 37349623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas.
    Kaimaktchiev V; Terracciano L; Tornillo L; Spichtin H; Stoios D; Bundi M; Korcheva V; Mirlacher M; Loda M; Sauter G; Corless CL
    Mod Pathol; 2004 Nov; 17(11):1392-9. PubMed ID: 15205684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
    Bayrak R; Haltas H; Yenidunya S
    Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical detection using CDX2: An aid for discerning tumor involvement in ascites cytology.
    Kobayashi M; Ueyama Y; Nakanishi H; Ishida H; Takahashi E; Nakamura S; Koshikawa T; Yatabe Y
    Cancer; 2006 Apr; 108(2):114-8. PubMed ID: 16541450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites.
    De Lott LB; Morrison C; Suster S; Cohn DE; Frankel WL
    Arch Pathol Lab Med; 2005 Sep; 129(9):1100-5. PubMed ID: 16119980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract.
    Long KB; Hornick JL
    Hum Pathol; 2009 Dec; 40(12):1768-73. PubMed ID: 19716157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
    Groisman GM; Meir A; Sabo E
    Int J Gynecol Pathol; 2004 Jan; 23(1):52-7. PubMed ID: 14668551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system.
    Su MC; Yuan RH; Lin CY; Jeng YM
    Mod Pathol; 2008 Nov; 21(11):1379-86. PubMed ID: 18552820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of cadherin 17 and down-regulation of homeodomain protein CDX2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer.
    Huang LP; Yu YH; Sheng C; Wang SH
    Int J Gynecol Cancer; 2012 Sep; 22(7):1170-6. PubMed ID: 22810971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumors.
    Jacobsen F; Pushpadevan R; Viehweger F; Freytag M; Schlichter R; Gorbokon N; Büscheck F; Luebke AM; Putri D; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Bernreuther C; Lebok P; Sauter G; Minner S; Steurer S; Simon R; Burandt E; Dum D; Lutz F; Marx AH; Krech T; Clauditz TS
    Pathol Res Pract; 2024 Apr; 256():155175. PubMed ID: 38452580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cadherin 17 in well-differentiated neuroendocrine tumours.
    Snow AN; Mangray S; Lu S; Clubwala R; Li J; Resnick MB; Yakirevich E
    Histopathology; 2015 Jun; 66(7):1010-21. PubMed ID: 25388236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.